BRETSCHNEIDER, Maxi Pia, Jan KLÁSEK, Martina KARBANOVÁ, Patrick TIMPEL, Sandra HERRMANN a Peter E. H. SCHWARZ. Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study. Nutrients. Basel: MDPI, 2022, roč. 14, č. 9, s. 1-17. ISSN 2072-6643. Dostupné z: https://dx.doi.org/10.3390/nu14091810.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study
Autoři BRETSCHNEIDER, Maxi Pia (276 Německo), Jan KLÁSEK (203 Česká republika), Martina KARBANOVÁ (203 Česká republika, domácí), Patrick TIMPEL (276 Německo), Sandra HERRMANN (276 Německo) a Peter E. H. SCHWARZ (276 Německo).
Vydání Nutrients, Basel, MDPI, 2022, 2072-6643.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30304 Public and environmental health
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.900
Kód RIV RIV/00216224:14110/22:00125808
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/nu14091810
UT WoS 000794653000001
Klíčová slova anglicky diabetes mellitus type 2; self-management; digital health; HbA1c; lifestyle intervention; digital intervention; mHealth
Štítky 14110525, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 23. 1. 2023 10:56.
Anotace
The aim of this study was to provide preliminary evidence on the impact of the digital health application Vitadio on improving glycemic control in patients with type 2 diabetes mellitus. This was a 3-month, prospective, multicenter, open-label trial with an intraindividual control group. Participants received a digital lifestyle intervention. HbA1c levels were observed at 3 time points: retrospectively, at 3 months before app use; at baseline, at the start of usage; and 3 months after the start of use. In addition, changes in other metabolic parameters (fasting glucose, body weight, and waist circumference), patient reported outcomes (quality of life, self-efficacy, and depression), and data generated within the app (frequency of use, steps, and photos of meals) were evaluated. Repeated measures analysis of variance with the Bonferroni correction was used to assess the overall difference in HbA1c values between the intervention and the intraindividual control group, with p < 0.05 considered significant. Participants (n = 42) were 57 +/- 7.4 years old, 55% male, and with a mean baseline HbA1c of 7.9 +/- 1.0%. An average HbA1c reduction of -0.9 +/- 1.1% (p < 0.001) was achieved. The digital health application was effective in significantly reducing body weight (-4.3 +/- 4.5 kg), body mass index (-1.4 +/- 1.5 kg/m(2)), waist circumference (-5.7 +/- 15 cm), and fasting glucose (-0.6 +/- 1.3 mmol/L). The digital therapy achieved a clinically meaningful and significant HbA1c reduction as well as a positive effect on metabolic parameters. These results provide preliminary evidence that Vitadio may be effective in supporting patient diabetes management by motivating patients to adopt healthier lifestyles and improving their self-management.
VytisknoutZobrazeno: 17. 5. 2024 02:45